Active Funding Opportunities and Notices for NICHD
NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.
NOTs and Active NOFOs for NICHD
Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.
Number | Exp. Date | Activity Code(s) | Title |
---|---|---|---|
NOT-OD-22-107 | May 8, 2025 | 333,R01,R34,R21,R61/R33,U01,UG3/UH3 | Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening |
NOT-OD-22-106 | May 8, 2025 | R03,R01,R34,R21,UG3/UH3,R61/R33,333 | Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan |
NOT-HD-22-007 | January 1, 2027 | Notice of Change to PAR-20-101 "Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)" | |
PAR-22-109 | May 8, 2025 | R21 | Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
PAR-22-105 | May 8, 2025 | R01 | Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
NOT-HD-22-020 | January 1, 2027 | Notice of NICHD Participation in PAR-22-116, International Bioethics Research Training Program (D43 Clinical Trial Optional)" | |
NOT-HD-22-019 | January 1, 2027 | Notice of NICHD Participation in NOT-CA-22-037, Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research" | |
PAR-22-106 | September 8, 2025 | R03 | Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) |
PAR-22-167 | October 18, 2024 | UG3/UH3 | Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) |
NOT-HD-22-021 | January 1, 2027 | Notice of NICHD Participation in PAR-22-118, International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)" | |
NOT-HD-22-018 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource Constrained Settings Implementation Science Network Clinical Research Centers | |
NOT-HD-22-008 | January 1, 2027 | Request for Information: Call for Nominations for NICHD's Best Pharmaceuticals for Children Act Priorities in Pediatric Therapeutics 2022-2023 | |
NOT-HD-22-013 | January 1, 2027 | Notice of Intent to Publish a Funding Opportunity Announcement for Maternal and Pediatric Precision in Therapeutics (MPRINT) Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed) | |
NOT-HD-22-003 | June 6, 2024 | 333 | Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities |
RFA-OD-22-008 | July 2, 2024 | R03 | Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed) |
NOT-HG-22-017 | January 1, 2027 | Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed) | |
NOT-GM-22-005 | October 18, 2024 | 333 | Notice of Special Interest (NOSI): Administrative Supplements for Research on Womens Health in the IDeA States |
RFA-OD-22-009 | July 2, 2024 | R01 | Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed) |
RFA-OD-22-007 | July 2, 2024 | R21 | INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed) |
RFA-OD-22-010 | July 2, 2024 | R61/R33 | Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required) |